Explore the latest advancements in treating ulcerative colitis using machine learning to discover new antimicrobial peptides.
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent intestinal inflammation, abdominal ...
Everyday Health on MSN
Why histological healing is the new benchmark for your ulcerative colitis
For people with UC, ‘feeling better’ is just the start. Learn why tissue-level (histological) healing is becoming the new ...
The American Gastroenterological Association has updated guidance for the treatment of ulcerative colitis to recommend using higher efficacy drugs in earlier stages of treatment, Medscape Medical News ...
A machine learning-based computational approach to accelerate therapeutic discoveryUlcerative colitis (UC) is a chronic inflammatory bowel disease ...
Ulcerative colitis (UC) is a chronic, immune-mediated inflammatory disorder of the colon that follows a relapsing-remitting ...
Everyday Health on MSN
How to manage a career and family during an ulcerative colitis treatment switch
Switching UC treatments while managing a career and home life can be a major challenge. Here’s how to navigate work logistics, family communication, and side effects.
How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...
Please provide your email address to receive an email when new articles are posted on . A greater proportion of patients in the PRA023 group achieved clinical remission at 12 weeks vs. placebo (26.5% ...
The MarketWatch News Department was not involved in the creation of this content. Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results